Skip to main content
mSystems logoLink to mSystems
. 2024 Feb 16;9(3):e00715-23. doi: 10.1128/msystems.00715-23

Genome-scale metabolic modeling of the human milk oligosaccharide utilization by Bifidobacterium longum subsp. infantis

Loreto Román 1, Felipe Melis-Arcos 1, Tomás Pröschle 1, Pedro A Saa 1,2, Daniel Garrido 1,
Editor: Jack A Gilbert3
PMCID: PMC10949479  PMID: 38363147

ABSTRACT

Bifidobacterium longum subsp. infantis is a representative and dominant species in the infant gut and is considered a beneficial microbe. This organism displays multiple adaptations to thrive in the infant gut, regarded as a model for human milk oligosaccharides (HMOs) utilization. These carbohydrates are abundant in breast milk and include different molecules based on lactose. They contain fucose, sialic acid, and N-acetylglucosamine. Bifidobacterium metabolism is complex, and a systems view of relevant metabolic pathways and exchange metabolites during HMO consumption is missing. To address this limitation, a refined genome-scale network reconstruction of this bacterium is presented using a previous reconstruction of B. infantis ATCC 15967 as a template. The latter was expanded based on an extensive revision of genome annotations, current literature, and transcriptomic data integration. The metabolic reconstruction (iLR578) accounted for 578 genes, 1,047 reactions, and 924 metabolites. Starting from this reconstruction, we built context-specific genome-scale metabolic models using RNA-seq data from cultures growing in lactose and three HMOs. The models revealed notable differences in HMO metabolism depending on the functional characteristics of the substrates. Particularly, fucosyl-lactose showed a divergent metabolism due to a fucose moiety. High yields of lactate and acetate were predicted under growth rate maximization in all conditions, whereas formate, ethanol, and 1,2-propanediol were substantially lower. Similar results were also obtained under near-optimal growth on each substrate when varying the empirically observed acetate-to-lactate production ratio. Model predictions displayed reasonable agreement between central carbon metabolism fluxes and expression data across all conditions. Flux coupling analysis revealed additional connections between succinate exchange and arginine and sulfate metabolism and a strong coupling between central carbon reactions and adenine metabolism. More importantly, specific networks of coupled reactions under each carbon source were derived and analyzed. Overall, the presented network reconstruction constitutes a valuable platform for probing the metabolism of this prominent infant gut bifidobacteria.

IMPORTANCE

This work presents a detailed reconstruction of the metabolism of Bifidobacterium longum subsp. infantis, a prominent member of the infant gut microbiome, providing a systems view of its metabolism of human milk oligosaccharides.

KEYWORDS: genome-scale metabolic models, GSMM, Bifidobacterium longum subsp.infantis, infant gut microbiome, bacterial metabolism

INTRODUCTION

Bifidobacterium species are early colonizers of the infant gut microbiota (1, 2). This genus includes Gram-positive, rod-shaped anaerobic, and nonmotile bacteria that are usually regarded as beneficial for the host (3, 4). Certain bifidobacteria are used as probiotics in the food industry for their multiple health-promoting activities (5). These microorganisms have a saccharolytic lifestyle, fermenting several carbohydrates with a preference for oligo and dietary polysaccharides (6).

The Bifidobacterium genus relies on the bifid shunt for central metabolism (7). This pathway is characterized by the presence of fructose-6-phosphate phosphoketolase (PKL), and it enables Bifidobacterium to produce more ATP per fermented glucose (2.5 ATP) than fermentative pathways present in other bacteria, e.g., two ATP in lactic acid bacteria (8). Essential enzymes in this shunt are fructose 6-phosphate erythrose 4-phosphate lyase (F6PE4PL), transaldolase (TALA), and transketolases (TK1 and TKT2), as well as ribose 5-phosphate isomerase and epimerase (6). Bifidobacterium metabolism theoretically produces acetate and lactate in a 3:2 ratio as end-products from hexoses (9). This ratio is indeed variable, and it depends on the nature of the substrate used for fermentation (10). The production of lactate and ethanol is useful for NADH regeneration (11), and the TCA cycle is incomplete in most Bifidobacterium (12). In addition, Bifidobacterium genomes display an enrichment in carbohydrate metabolism genes (1315). These include exo- and endoglycolytic enzymes that target complex carbohydrates, ABC transporters, and feeder pathways deriving carbohydrates into the bifid shunt (1618). Genomic and functional studies have shown that these microorganisms have coevolved with the host and display an extensive array of adaptations for the infant gut environment (19, 20).

Human milk contains high concentrations of human milk oligosaccharides (HMOs) compared to other mammals (21). They represent a diverse family of structures with a degree of polymerization from 3 to 15 (22). HMOs represent a high-energy investment from the mother, aimed at providing the newborn with a healthy microbiota dominated by Bifidobacterium species (23). Some HMOs contain sialic acid residues (NeuAc; e.g., 6'-sialyllactose; 6′SL), fucose (Fuc; e.g., 3'-fucosyllactose; 3′FL), or nondecorated with these residues (e.g., lacto-N-neotetraose; Galβ1–4GlcNAcβ1–4Galβ1–4Glc; LNnT, among others) (18). Several infant gut-associated bifidobacteria specialize in HMO consumption (24, 25). Bifidobacterium longum subsp. infantis (B. infantis) is one of the most studied microorganisms for its ability to utilize different HMOs (26, 27). It possesses several genomic and functional adaptations for intracellularly accessing and degrading small HMOs (3′FL and 6′SL) or longer ones (28). B. infantis contains multiple ABC transporters that import HMOs and various glycoside hydrolases, including α-fucosidases and α-sialidases (17, 29). These genomic patterns are well conserved in the subspecies infantis (3032) and described in other species such as Bifidobacterium breve and some strains of B. longum subsp. longum (18).

Genome-scale metabolic models (GSMMs) are powerful mathematical structures that provide a coherent representation of cell metabolism, enabling a better understanding of metabolic behaviors and microbial adaptations under different scenarios (33, 34). To improve their prediction capabilities, computational methods integrating additional omics data, such as transcriptomics, have been developed and evaluated (35, 36). These tools, paired with high-quality metabolic models, have provided a helpful platform for probing cellular metabolism and increasing our knowledge about bifidobacterial metabolism (7, 12, 37)

Although B. infantis is a model microorganism for HMO utilization, the active metabolic pathways, fluxes, and metabolite exchange reactions associated with the metabolism of distinct HMOs molecules remain poorly understood. To address this limitation, a refined genome-scale network reconstruction of B. infantis metabolism (iLR578) was built consistent with recent literature information and transcriptomic data. The former reconstruction was then employed to generate four context-specific GSMMs describing growth on distinct carbon sources such as lactose or HMOs such as LNnT, 3′FL, and 6′SL. Our results revealed emergent patterns of metabolic adaptations of B. infantis under different HMOs utilization conditions.

MATERIALS AND METHODS

Genome-scale network reconstruction and model building

Reconstruction and refinement of B. infantis (iLR578) metabolic network involved multiple steps (Fig. 1). First, data from multiple databases and references were employed to define gene-protein-reaction (GPR) relationships for each gene in the reconstruction. This process is used as a template for the reconstruction of Bifidobacterium_longum_infantis_ATCC_15697 from AGORA 1.03 (Assembly of Gut Organisms through Reconstruction and Analysis) (38) and integrated genome annotation information for this strain (39). Genes were manually translated from PEG to Blon annotation using the SEED database (40). Context-specific metabolic models were constructed using computational reconstruction tools from COBRA Toolbox v3.0 for MATLAB (41). Transcriptomic data from a previous study (28) were used to confirm gene expression under different carbon sources (see below). This information was integrated into each metabolic model and employed to gap-fill the model using flux balance analysis (FBA) to maximize the specific growth rate as a biological objective (42). Additional reactions and metabolites were added until the list of experimentally expressed genes was consistent with the network reconstruction in all carbon sources. Moreover, the removal of reactions and genes without experimental support or evidence against their presence in the template model was also carried out (Supplemental Data). Finally, two biomass reactions were employed to simulate growth: a generalized reaction in the original AGORA v1.03 reconstruction and a recent biomass reaction from a close strain (B. longum) (12).

Fig 1.

Fig 1

Metabolic network reconstruction and refinement workflow for building iLR578 and context-specific models of B. infantis metabolism.

For the initial integration of the model with transcriptomics data, normalized counts for each gene and condition were determined using a variety of preprocessing and normalization steps (see next section). Then, reactions associated with each expressed gene were evaluated for their capacity to carry flux while allowing biomass growth (Supplemental Data). The list was checked manually, and reactions and metabolites were added based on information from KEGG pathways (43) and BiGG Models (44). Finally, the quality of the metabolic reconstruction was assessed with the open tool MEMOTE (MEtabolic MOdel TEst suite) (45).

Transcriptomics data quality control and preprocessing

Preliminary analysis of the transcriptomic data suggested a potential contamination with reads of another Bifidobacterium (Bifidobacterium bifidum). For this task, a quality control step was performed using FastQC (46) and MultiQC (47), and low-quality reads were trimmed using Trimmomatic (48) with the following parameters: leading 3, trailing 3, sliding window 3:15, and minlen 36. To eliminate B. bifidum reads, the transcriptomic libraries of B. infantis were aligned to the B. bifidum genome using bowtie2 (49). Subsequently, samtools was used to obtain the read identifiers. Using BBMap and Hisat2 (50, 51), reads mapped to B. bifidum were removed from the data set. To assess the removal effect of filtered libraries, a principal component analysis was conducted to compare the behavior of the counts data of replicates under different conditions (Fig. S1). After removing the contaminated libraries, the processed data displayed a similar behavior for all but two conditions (2'-fucosyl lactose and lacto-N-neotetraose), forming clusters at approximately the same locations. This pointed to a robust data set behavior, supporting the execution of the next steps. The preprocessed data were finally normalized using the median of ratios method from the DESeq2 (52) package to enable analysis across conditions.

Growth simulation under different carbon sources

FBA simulations were performed to probe B. infantis metabolism under different carbon sources. Gurobi 9.0.1 (Beaverton, Oregon) was employed as a linear programming solver in all computations. Briefly, FBA (equation 1) solves a linear optimization problem whose objective is to maximize the flux through the biomass reaction in the model. S is the stoichiometric matrix, v is the metabolic flux vector, and μ ⊂ support(v) is the specific biomass growth rate (objective function). Upper and lower bounds for the reaction fluxes are captured by the ub and lb vectors, respectively. These vectors are defined according to each simulated condition such that they support growth in a defined in silico medium with distinct exchange reactions potentially active. Reactions associated with genes not expressed based on transcriptomic data have both bounds set to zero.

Max. μs.t.Sv=0lbvub (1)

Typically, the linear optimization formulation in equation 1 has multiple alternative optimal flux solutions. An FBA variant known as parsimonious FBA (pFBA) (53) was employed to determine a biologically relevant flux distribution. This method is known to produce flux distributions that approximate optimal enzyme usage and avoid infeasible loops (5456). In addition, flux variability analysis (FVA) was employed to evaluate alternative solutions by computing the flux ranges for relevant reactions (i.e., network flexibility) under (sub)optimal conditions (57).

The in silico medium used for all simulations was based on a modified Man Rogosa Sharp medium containing 2% (wt/vol) of each carbon source. The carbon sources were lactose and three HMOs: LNnT, 3′FL, and 6′SL. To compare yield calculation across conditions, the total number of moles for each substrate contained in 200 µL at 2% (wt/vol) was calculated and later normalized by the moles of lactose. Other carbon sources were also normalized by the moles of lactose for a fair comparison (Table S1). Similarly, amino acids, vitamins, and nucleotides were proportionally normalized and asserted that they did not limit growth. Bounds for alternative carbon sources absent in the media were set to zero.

Evaluation of the refined metabolic model prediction capabilities

The third step was the evaluation of the prediction fidelity of the model. Simulated growth of context-specific models was validated against experimental data (28) and literature (16, 5867). Data on growth rates, metabolite consumption, and production (10) were used to assess model predictions. Briefly, a binary analysis was performed where the experimental growth of B. infantis on different carbon sources was compared against in silico predictions. In this case, four outcomes can be obtained. A true positive (TP) indicates that both the model and data indicate growth on a particular condition; a false positive (FP) implies the model can grow on a given substrate but is not supported by the experimental evidence; a true negative (TN) indicates that both the model and data agree that no growth is observed; and, a false negative (FN) implies the model does not support growth, but experimental evidence does. The F-score is a standard measure of the prediction capabilities of the model (equation 2) (68)]. Additionally, Matthew’s correlation coefficient (MCC) was also calculated as it is regarded as a stricter measure of prediction power, producing a high score (MMC = 1) only if the prediction obtained good results in the outcomes above (69) (equation 3).

F=TPTP+12(FP+FN) (2)
MCC=TP*TN-FP*FNTP+FP*TP+FN*TN+FP*(TN+FN) (3)

Transcriptomic data integration

The fourth step was integrating transcriptomics data into the model. For this task, RNA-seq data from Garrido et al. (28) for Bifidobacterium (particularly B. infantis ATCC 15697) growing exponentially on lactose and three HMOs (3′FL, 6′SL, and LNnT) were employed. The GIMME algorithm (35) was applied to build four context-specific models. Briefly, GIMME uses a user-defined expression threshold corresponding to the 30th percentile to determine if a gene has a low/high expression and then deactivates the reactions below the former. This choice is based on typical choices reported elsewhere (35) and yielded similar simulation results (Table S13). Simply put, this algorithm minimizes the usage of low-expression reactions while maximizing the biomass reaction flux (biological objective). In this way, the resulting model achieves greater consistency with the available data and assumed biological objective (35). Reactions with an “AND” GPR association are associated with the corresponding lowest expressed gene, while those with an “OR” GPR association are associated with the corresponding highest expressed gene.

Gene essentiality analysis and flux-gene expression maps

Essential gene lists were generated by simulating single-gene deletions in all conditions. An essential gene is defined as a gene that, when knocked out, causes null growth. The corresponding reactions were identified as essential reactions. To visualize flux distribution results after FBA simulations, metabolic maps were generated using Escher (70), an online application for the integrated visualization of flux and transcriptomic data. MAT models were translated to JSON format and then uploaded to Escher, along with fluxes and a transcriptomic data table to visualize network expression maps. An integrated map for each condition was manually generated.

Flux coupling network analysis

To reveal emergent metabolic properties under each growth condition, Flux coupling analysis (FCA) was performed using the F2C2 tool version 0.95b (71) to reveal flux dependencies (coupling) between reactions under each condition. For this task, we filtered networks encompassing major end products that contained exchanges for lactate, acetate, succinate, formate, ethanol, and 1,2-propanediol (1,2-PD) in each condition. Coupled reaction networks were identified, and their topological parameters were calculated and visualized using Cytoscape (72) as in Dal’Molin et al. (73). Finally, to visualize differences in connectivity between the four context-specific models, we built a consensus network with Dynet (74). For each node, the linkages shared between two or more networks and those unique to each network were identified. Then, changes (rewiring) were quantified using the rewiring score metric (Dn-score [74]).

RESULTS

Reconstruction and refinement of a GSMM for B. infantis

In this work, we combined metabolic modeling and transcriptomics to refine and expand the metabolism of B. infantis during the utilization of lactose and three HMOs (3′FL, 6′SL, and LNnT). The workflow followed is presented in Fig. 1. The initial AGORA model had 541 genes in PEG annotation, 1,005 reactions, and 889 metabolites in two different compartments (Table 1).

TABLE 1.

Reaction content comparison for different reconstructions

Reaction features AGORA v1.03 iLR578
Total number of reactions 1,005 1,047
Universally blocked reactions 279 287
Metabolic reactions 714 760
Transport reactions 133 135
Reactions with GPR associations 689 893

To integrate the genome-scale transcriptomics data into the metabolic model, the PEG annotation was manually translated to Blon annotation using the SEED database (75), yielding Draft Model v1.0 (Fig. 1). One PEG gene did not have a match in the Blon annotation, but it had a match in another B. infantis genome (BLIJ_2570, “pbiosynthesis”). This reaction had several genes in OR association, so it was assumed unimportant (Supplemental Data). Then, genes associated with reactions and metabolites involved in HMOs utilization were added to the reconstruction. This addition expanded the gene list to 546 genes, with 1,021 reactions and 900 metabolites (Fig. 1). Finally, GPR relationships were included for each gene based on the available experimental and reported information.

The model was later integrated with transcriptomics data. Reactions associated with expressed genes were individually checked to see if they could carry flux while ensuring biomass production under each condition. For this task, a generic GSMM of B. infantis was built using the current reconstruction, expression, and carbon source uptake data, thereby enabling the assessment of its growth capabilities using (p)FBA (76). In this step, 23 reactions, 24 metabolites, and 32 genes were mapped and incorporated into the model. Relevant GPRs were recovered from a previous model (12). In addition, two biomass reactions and the nongrowth-associated maintenance energy were included, although the latter was not constrained due to the lack of data. The list of blocked reactions contained 20 genes associated with 33 reactions; these were blocked in the model (i.e., carried zero flux) but are present as expression data supports them (Table S2).

The resulting metabolic model was labeled iLR578, a functional GSMM able to produce biomass for B. infantis in all the studied conditions. The latter model contained 578 genes, 1,047 reactions (893 are gene-associated), and 924 metabolites (Table 1). Metabolic reactions represented 72.6% of total reactions (760 reactions), whereas transport and exchange reactions were 135 and 149 (12.9% and 14.2% of the total number of reactions, respectively; see Table 1). While the number of blocked reactions slightly increased, the number of metabolic reactions mapped onto iLR578 also grew from 714 (AGORA v1.03) to 760 (6.4% net increase; Table 1). Notably, the numbers of genes, reactions, metabolites, and GPRs of iLR578 are higher than other related bifidobacterial GSMMs reported to date (7). For instance, the current model B. infantis ATCC 1,597 has 541 genes, 1,005 reactions, and 889 metabolites, whereas B. longum subsp. longum 157F has 519 genes, 914 reactions, and 853 metabolites. This could correlate with the larger genome size of B. infantis ATCC 15697 (15). Notably, while the general reconstruction indicators of iLR578 were improved over the AGORA v1.03 reconstruction (Table 1), the MEMOTE score—a quality metric standard for genome-scale network reconstructions—did not increase (in both cases, the score was 43, Supplementary Data), despite having an increase of 16.1% of mapped metabolites.

The MEMOTE score evaluates GSMMs compliance with community sharing and annotation standards, incorporation of relevant meta-data (e.g., annotations, GPRs, metabolite formulas, etc.), as well as different simulation checks (e.g., growth feasibility, flux cycles, and metabolic imbalances predictions, among others) (45). Yet, this suite does not cover specific metabolic capabilities under different conditions and their consistency against experimental data. Experimental evaluation of the predictive power of iLR578 is assessed in the next section.

Model prediction evaluation: growth and metabolic profiles

Exponential phase growth data from a previous study using four different carbon sources (28) was employed to evaluate the predictive power of the iLR578, checking biomass production under anaerobic conditions using pFBA. Before this analysis, the prediction capabilities of the two biomass reactions were evaluated. Results showed that the generalized biomass reaction from AGORA was superior, reaching a 55.3% lower root-mean-square error (RMSE) when predicting the specific growth rate under the assumption of biomass maximization (mean RMSE 0.048 vs 0.108 h−1; Table S6). These results are somewhat to be expected, considering that there is a twofold difference in the growth-associated maintenance energy (GAM) of the two reactions (20 mmol·gDCW−1 vs 40 mmol·gDCW−1 for the Schöpping et al. and AGORA biomass reactions, respectively; Supplementary file). Besides, out of the 74 precursors of the biomass reaction reported by Schöpping et al. (12), 64 could be successfully mapped onto the iLR578 model (Supplemental file ). It is worth noting that the latter biomass reaction was developed for B. longum subsp. longum BB-46 growing on sucrose (12), which greatly differs from the simulation conditions of this study. In fact, even when adjusting and equating the GAM parameter, the latter equation displays a slightly higher RMSE than the AGORA v1.03 biomass reaction (2% greater; Table S6). Considering these results and the lack of additional experimental data under the studied conditions (e.g., chemostats under various dilution rates) and/or gene essential data, we decided to employ the AGORA v1.03 biomass reaction for the remaining of the study.

A theoretical ratio of 3:2 is expected for acetate to lactate in the B. infantis metabolism (6), so the former was imposed in the subsequent flux calculations. To assess the impact of the magnitude of the production ratio, the latter was set to vary from 2.5:2 to 3.5:2 of acetate to lactate. Results showed no statistically significant differences in the predicted specific growth rates (one-way ANOVA P-value = 0.971, data available in Table S7) or the maximum biomass yields (one-way ANOVA P-value = 0.987, data available in Table S8). Although only a modest increase (1.7%) in the predicted specific growth rate was determined when imposing a 3.5:2 ratio production of acetate to lactate (Table S7), this ratio condition will be employed in the following for the analysis.

Experimental biomass yields were similar for LNnT and approximately twice that of 3′FL and 6′SL (Table 2). Prediction of biomass yields on LNnT agreed with model predictions using pFBA. However, predictions in the remaining conditions overestimated the biomass yield except for lactose (Table 2). The production yields of major metabolic end products, such as lactate, acetate, ethanol, and succinate, were also evaluated under the assumption of biomass growth maximization (Table 3). Again, there were no substantial differences when employing different production ratios of acetate to lactate (Table S9 and S10). LNnT, 3′FL, and 6′SL are HMOs that contain lactose as a building block. Model predictions showed higher acetate and lactate yields on lactose followed by 6′SL. Overall, low formate and no succinate production were determined in silico. Fucose metabolism in Bifidobacterium uniquely results in pyruvate and 1,2-PD (64) as an end-product (Table 3). Application of flux fariability analysis for the determination of the yield ranges for the major end products under near-optimal conditions (i.e., 99% of the optimal specific growth rate) produced tight ranges, pointing to similar results and confirming the observed metabolic trends shown in Table 3 (Table S11). Most notably, even when the ratio constraint for acetate and lactate is relaxed under near-optimal conditions, the computed yield ranges are only slightly larger, and they overall display the same trends, i.e., high acetate and lactate production and very low formate and ethanol, and no succinate (Table S12).

TABLE 2.

Experimental and predicted maximum biomass yield (103⋅gdcw⋅g−1) by iLR578 under different carbon sources

Carbon source Experimental yielda In silico yield prediction from iLR578 In silico yield prediction from contextualized iLR578 models
Lactose 28.0 15.2 13.9
LNnT 21.3 19.0 17.9
3FL 14.8 33.6 30.3
6SL 13.1 24.7 22.2
a

Data taken from Garrido et al. (16), Garrido et al. (77), Garrido et al. (10), and Garrido et al. (28). Yields were calculated assuming a 3.5:2 acetate to lactate production ratio based on experimental observations. This ratio maximized the specific growth rate for all substrates and was therefore chosen for subsequent analyses (Table S11).

TABLE 3.

Yield of major metabolites (g⋅gDW−1) predicted by iLR578 assuming biomass maximization under different carbon sourcesa

Metabolite Carbon source
Lactose LNnT 3FL 6SL
1,2-PD 0 0 0.76b 0
Acetate 2.40b 2.50 2.72 2.66
Ethanol 0.02b 0.02 0.02 0.02
Formate 0.02c 0.02 0.02 0.02
Lactate 2.10b 2.18 2.38 2.32
Succinate 0c 0 0 0
a

Evidence for metabolite production taken from Garrido et al. (10), Van der Meulen et al. (11), and Cheng et al. (78). Yields were calculated assuming a ratio of 3.5:2 acetate to lactate production ratio as in Table 2.

b

Production was observed experimentally.

c

No production was observed experimentally.

Finally, iLR578 showed an increase in sensitivity and F-score compared to the initial AGORA v1.03 model when predicting the growth of various carbon sources (Table 4; Table S4) (68). The former model had 34 TP, four FPs, and four FN. This increase was explained by iLR578 having more TPs and fewer FNs than the original model. Amino acid metabolism appears to be accurately represented by the metabolic model, considering B. infantis is only auxotrophic for L-cysteine (79). The F-score of 89.4% indicates that there is still space to improve the metabolic predictive capabilities of the model. Bifidobacterium genomes usually have many hypothetical proteins, and their metabolism is still not completely understood (15). A higher MCC value for iLR578 compared to the initial model corroborates the improvements made to this GSMM (Table 4).

TABLE 4.

Performance comparison of GSMMs of B. infantisa

Performance indicator AGORA v1.03 iLR578
TP 29 34
TN 6 6
FP 4 4
FN 9 4
Sensitivity 0.743 0.755
Specificity 0.555 0.555
F-score 0.783 0.894
MCC 0.309 0.482
a

Data available in Table S4.

Context-specific models of HMO utilization based on transcriptomic data integration

Context-specific GSMMs were built from iLR578 and transcriptomic data on each HMO (Fig. 2). This integration resulted in four carbon source-specific models for 3′FL, lactose, 6′SL, and LNnT (Fig. 1; Supplemental Data). The highest number of deactivated transcriptionally turn-off reactions was observed in the LNnT model, with 152 reactions, followed closely by the 6′SL model (153 reactions), then the 3′FL model (145 reactions), and finally, the lactose model, with 140 deactivated reactions (Fig. 1). Context-specific models showed similar biomass yields compared to the generic iLR578 (Table 2).

Fig 2.

Fig 2

Gene expression maps of central carbon metabolism of B. infantis under different carbon sources. Each arrow describes a reaction, and its color intensity and width are proportional to the corresponding gene expression. Metabolic pathways depicted include substrate uptake (top), bifid shunt (middle), and major fermentation products (bottom). Panels describe growth under different carbon sources, namely, (A) 3′FL, (B) lactose, (C) 6′SL, and (D) LNnT. Metabolite nomenclature and gene symbols are found in the Supplemental Data.

We first analyzed gene expression patterns in these context-specific models. 3′FL is correctly imported by an ABC transporter and degraded intracellularly, generating fucose and lactose (Fig. 2A). Gene expression for genes converting lactose in galactose and glucose (including the Leloir pathway) and their conversion to glucose-6-phosphate was medium to high. Similarly, the putative fucose metabolic pathway showed medium to high expression, resulting in the production of 1,2-PD through lactaldehyde reductase (Blon_0540), acetate (Blon_1731; acetate kinase), and lactate (Blon_ 1090 or Blon_0840; lactate dehydrogenase). Therefore, this context-specific model can capture microbial growth and metabolism of B. infantis in 3′FL, resulting in biomass and metabolite production.

The lactose model showed similar gene expression patterns as 3′FL, without fucose metabolization and 1,2-PD production (Fig. 2B). It showed an increased gene expression for reactions at the entry of lactose through lactose permease to the bifid shunt until the production of lactate and acetate (Fig. 2B). Formate and succinate production was lower than acetate and lactate, which correlated with a lower gene expression of Blon_1714, Blon_1715 (pyruvate formate lyases, PFL), and Blon_2035 (dihydrodipicolinate synthase, DHDPS), respectively.

6′SL is imported intracellularly in B. infantis (18); however, the transporter is unknown. Like other HMO, 6′SL is likely imported by an ABC transporter. While gene expression supported a 6′SL-derived lactose metabolization like 3′FL or lactose, sialic acid utilization resulted in additional pyruvate and acetate production, with increased gene expression of the overlapping aminosugar metabolic pathway (Fig. 2C; Blon_0644, N-acetyl-D-mannosamine kinase; Blon_0645, N-acetylmannosamine 6-phosphate epimerase; Blon_0882, N-acetylglucosamine-6-phosphate deacetylase; Blon_0881, glucosamine-6-phosphate deaminase). However, certain enzymes in the sialic acid metabolism showed a low or null gene expression, which could indicate that other genes participate in this process, or B. infantis does not fully use sialic acid.

Finally, LNnT is a tetrasaccharide that, according to its model, generates intracellular galactose, lactose, and GlcNAc (Fig. 2D). According to gene expression, galactose and lactose follow similar processing steps as above. B. infantis β-hexosaminidases, releasing GlcNAc from LNnT, have a constitutive gene expression (Fig. 2; Blon_0459, Blon_0732, Blon_2355). Later, GlcNAc is metabolized by Blon_0879 (N-Acetylglucosamine Kinase), Blon_0881, and Blon_0882 as above.

Gene expression in the context-specific metabolic models showed several reactions with unexpected or crossed expressions. Some examples are the expression of LNnT transport and GlcNAc metabolism in the presence of 3′FL (Fig. 2A), α-fucosidases during growth in lactose, 6′SL, and LNnT (Fig. 2B through D), and some fucose metabolizing enzymes during growth in LNnT (Fig. 2D). As described previously (28), B. infantis is likely prepared to use multiple HMOs simultaneously, suggesting that HMOs are not usually sensed as only one molecule by B. infantis.

Comparison of flux patterns and gene expression in the central metabolism of iLR578 under each carbon source

Fluxomics data showed less complex patterns than transcriptomics (Fig. 3). No crossed reactions were observed when considering metabolic fluxes. Metabolic fluxes were favored through the bifid shunt pathway in all HMOs and lactose (Fig. 3), with differences in feeder pathways according to the nature of the compound. In all four distribution maps, the carbon flux goes from sources to products, favoring the production of lactate and acetate in the previously set ratio. Reactions in the bifid shunt presented relatively high fluxes during consumption of these four substrates, which correlated with an increased gene expression (Fig. 2 and 3). They include enzymes such as fructose-6-P erythrose-4-P lyase (F6PE4PL or F6PPK), transaldolases and transketolases (TALA, TKK1, and TKK2), and PKL. The main products of the bifid shunt, acetyl-P, and GA3P were further metabolized into acetate and lactate (Fig. 3).

Fig 3.

Fig 3

Flux distribution maps of central carbon metabolism of B. infantis integrating transcriptomics data. Each arrow describes a reaction, and its color intensity and width are proportional to the corresponding flux value expression. Metabolic pathways depicted include substrate uptake (top), bifid shunt (middle), and major fermentation products (bottom). Metabolic maps were generated using GIMME assuming specific growth rate maximization. Panels describe growth under different carbon sources, namely, (A) 3′FL, (B) lactose, (C) 6′SL, and (D) LNnT. Metabolite nomenclature and gene symbols are found in the Supplemental Data.

Figure 3B shows the flux distribution for central pathways in B. infantis during lactose utilization, the simplest of the substrates evaluated. Lactose is predicted to be imported by a lactose permease and hydrolyzed by a β-galactosidase. The fluxes of these reactions and galactokinase showed medium flux values (Fig. 3B). Galactose and glucose are derived into central metabolism by feeder pathways such as the Leloir pathway, which includes gene products such as UDPG4R (UDP-glucose-4-epimerase), GALU (UTP-glucose-1-phosphate uridylyltransferase), and UGLT (UDPglucose-hexose-1-phosphate uridylyltransferase). The fluxes of these intermediate reactions were predicted to be high (Fig. 3B).

Metabolic analysis indicates that 3′FL and 6′SL show an even flux distribution between fucose/sialic acid and lactose metabolism pathways (Fig. 3A and C). In these substrates, lactose metabolism fluxes were lower (green) than lactose as the sole carbon source (yellow). Flux distribution captured well the production of 1,2-PD and pyruvate in 3′FL, which was not produced in any other substrate (Fig. 3A), and how sialic acid generates glucosamine and pyruvate (Fig. 3C). Finally, LNnT overall metabolic fluxes were similar to 6′SL, probably due to NeuAc metabolism overlapping with GlcNAc (Fig. 3D).

Some reactions were active in the TCA cycle, but with a low flux, producing formate or ethanol (Fig. 3). Albeit at different levels, the models reflected well the production of lactate and acetate. The four models displayed low fluxes of formate and ethanol (Fig. 3), associated with pyruvate-formate lyase (Blon_1714 and Blon_1715) and alcohol dehydrogenase (Blon_2241), also showing low but positive fluxes. The models did not predict succinate fluxes, contrasting with the low but positive gene expression of enzymes such as succinyl-CoA synthetase (Fig. 2 and 3).

Finally, the metabolic models indicate the coupling of two reactions catalyzed by GF6PTA (glutamine-fructose-6-phosphate transaminase; Blon_2018) and G6PDA (glucosamine-6-phosphate deaminase; Blon_0881). The net result of their action is the deamination of glutamine for NH4+ release (Supplemental Data), which might indicate the models couple these reactions in the absence of ammonia. The expression of Blon_0881 was high in 6′SL and LNnT but not lactose or 3′FL, which correlates with this enzyme-generating glucosamine. Blon_2018 showed a low gene expression across all four conditions. However, metabolic modeling estimated high fluxes for these two reactions, which might be an artifact due to ammonia limitation.

The metabolic activity of almost all bifid shunt and lower glycolysis enzymes correlated with gene expression data (Fig. 4A). To assess this effect, genes expressed consistently across all conditions and their corresponding reactions were mapped, and their linear correlation coefficients were analyzed. When the absolute correlations distribution for each consistently expressed gene and the corresponding reaction was assessed, there was only a slight enrichment in the mean absolute correlation of central carbon reactions and associated genes (0.61 vs 0.56, Fig. 4B), albeit this was not statistically significant with a high confidence level (P-value = 0.360 > 0.05, Wilcoxon rank sum test). Overall, fluxes correlated well with gene expression, particularly in central carbon metabolism, supporting the integration of this information for gaining insights into the active metabolic pathways under each condition.

Fig 4.

Fig 4

Correlation analysis between gene expression and metabolic fluxes in B. infantis utilizing different substrates. (A) Correlation between genes expressed consistently across all conditions and their corresponding reactions. In red, the flux and corresponding expression of central carbon metabolism genes expressed in all conditions are shown (n = 37), whereas in blue, the flux and corresponding expression of all genes expressed in all conditions are shown (n = 201). (B) Absolute correlation distribution for each consistently expressed gene and the corresponding reaction. While there is a slight increase in the mean absolute correlation of central carbon reactions and genes (0.61) vs all reactions and expressed genes (0.56), albeit this was not statistically significant (P-value = 0.360 > 0.05, Wilcoxon rank sum test).

Gene essentially simulations and analysis

Genes are predicted to be essential when their deletion results in an in silico growth rate of zero. The accuracy of these calculations in less studied microorganisms ranges typically between 60% and 80% (80). While there are no experimental gene lethality studies of B. infantis in the literature, this analysis could provide helpful information for better understanding metabolic limitations. Of the 578 genes of iLR578, 81 (14%) were predicted to be essential and common to all carbon sources (Table S3). As expected, genes related to critical cellular functions such as replication, translation, cargo (demand and transport reactions, 38.3%), amino acid, nucleotide, nitrogen metabolism (19.8%), and vitamins metabolism (6.2%) were most predicted to be essential (Table S5). Regardless of the carbon source, 397 genes (68.7%) did not affect biomass growth. Most of these were related to transport and demand reactions (approximately 11%).

Some genes were predicted to be nonlethal, albeit they caused a reduction in the computed growth rate. There were 76 genes of this type across the three HMOs studied (Supplemental Data). Blon_2152 (phosphoglycerate mutase) was previously predicted as an essential gene for B. infantis (7), and using iLR578, an approx. 51% reduction in growth was indicated by a single knockout. Genes predicted to be nonlethal with reduced growth rates are related to carbon source-specific pathways, ATP production, bifid shunt enzymes, and biomass-demanding metabolites (Supplemental Data).

Identification of metabolic clusters involved in SCFAs production under different conditions

To better understand the release of major metabolites by B. infantis under different growth conditions, we analyzed how exchange metabolites are coupled to metabolic reactions in each context-specific model (Fig. 5). For this analysis, we again considered and imposed a 3.5:2 production ratio of acetate to lactate. The selected exchange reactions for network construction were lactate, acetate, succinate, formate, ethanol, and 1,2-PD. Connected networks of both partially and fully coupled reactions were identified (Fig. 5). Fully coupled reaction pairs are those where the increase/decrease in the flux value of one reaction causes a fixed increase/decrease in the flux of the other and vice versa (81). In the case of partially coupled reaction pairs, the extent of the increase/decrease exerted by one reaction on the other is variable and not necessarily the same in the opposite direction (81).

Fig 5.

Fig 5

Coupled reaction networks for each context-specific model derived from FCA. For each carbon source, major fermentation metabolites, namely, lactate, acetate, succinate, formate, ethanol, and 1,2-PD (red rectangles), are depicted linked to reactions coupled to them in each condition (colored ovals). Panels describe network generated under different carbon sources, namely, (A) 3´′FL, (B) 6′SL-LNnT (identical networks), and (C) lactose. The legend on the right indicates the type of reaction coupling (partial or full—dashed or solid line, respectively), edge betweenness (line thickness), and reactions subsystems (color coded). Reaction nomenclature can be found in the Supplemental Data.

The network topology for 6′SL and LNnT was identical (Fig. 5). We found that the network for 3′FL was only composed of fully coupled reactions, whereas lactose, LNnT, and 6′SL had both fully and partially coupled reactions (Fig. 5). The network with the highest number of nodes was lactose, far more than the other HMOs (Table 5). Interestingly, the 3′FL network displayed the highest clustering coefficient (0.45), whereas the lactose network showed the lowest (0.29) despite having similar network sizes (Table 5). This result suggests a more coordinated—and possibly regulated—network underpinning metabolite production under LNnT than lactose. The latter was confirmed by the increased network connections (edges). Lastly, we also evaluated the effect of the acetate-to-lactate ratio on the reaction coupling and generated the reaction networks without this constraint. The resulting networks were almost identical in size and contained fewer edges as expected due to the lower number of coupled reactions (Fig. S2). Of the four networks, three maintained the number of nodes but reduced the number of edges (Fig. S2). The only exception was the LNnT network, which reduced its number of edges from 22 to 17 and now shares the same topology as the 6′SL network (Fig. S2). Notably, while the lactose network did not show a decrease in the number of nodes, its connectivity decreased substantially from 76 to 35, rendering a more disconnected network (Fig. S2). The networks remained almost identical in size and displayed similar topologies—except for lactose—suggesting the presence of specific network motifs under each condition regardless of the forcing ratio constraint.

TABLE 5.

Topological properties of reaction networks found with FCA

Context-specific modela Number of nodes Number of edges Clustering coefficient
3′FL 17 38 0.45
6′SL 22 43 0.34
LNnT 22 43 0.34
LAC 34 76 0.29
a

Reaction networks for 6SL and LNnT were identical.

In all identified networks, their degrees followed a power law (scale-free) distribution, which provides a robust network structure against random failure/perturbations (82). Lactate, acetate, ethanol, and formate are usually clustered in the same network with their corresponding transporters (Fig. 5). Interestingly, succinate exchange usually formed a separate network from other metabolites (Fig. 5).

A global network coupling metabolites and fluxes across all four substrates is shown in Fig. 6. The Dynet analysis showed the most rewired nodes considering all four networks in Fig. 4. 1,2-PD and succinate clustered separately and were coupled to different reactions compared to lactate, acetate, formate, and ethanol (black nodes; Fig. 6). White nodes indicate reactions always coupled with these metabolites; light red nodes are reactions with a high degree of coupling. For example, lactate, acetate, formate, and ethanol appeared to be highly coupled to an alcohol dehydrogenase (ALCD2x), as well as to several reactions related to adenine and purine metabolism [ADSL, AICART, ADPT, ADSS, and EX_ade(e)]. As expected, reactions coupled to 1,2-PD were related to fucose metabolism, especially lactaldehyde reductase (LCARS). Finally, succinate was associated strongly with reactions of arginine biosynthesis, sulfate and sulfite metabolism, and succinate dehydrogenase.

Fig 6.

Fig 6

Comparison of network rewiring for building a consensus coupled reaction network. Consensus networks were constructed from all four context-specific networks using the DyNet tool. The network comprises 53 nodes and 131 edges. Black nodes represent major metabolite exchange reactions that were subject to the analysis, whereas white nodes describe reactions present in all context-specific networks. The red-shaded nodes are only present in some of the networks. Reaction nomenclature can be found in the Supplemental Data.

DISCUSSION

GSMMs are robust mathematical structures representing microbial metabolism, useful for understanding and optimizing metabolic pathways and microbial interactions (76). In this study, a functional GSMM of B. infantis was built using available transcriptomic and bibliomic information to understand HMOs utilization by this microbe. This general reconstruction served as the basis for the generation of four context-specific models describing growth on different HMOs: lactose, LNnT, 3′FL, and 6′SL. This model advances current models of Bifidobacterium, especially in the context of HMO utilization. A comprehensive literature search with multiple metabolites and reactions of carbohydrate consumption being used for this microorganism and the inclusion of global gene expression data helped provide a more precise and accurate representation of the consumption of HMOs by B. infantis.

One of the most challenging tasks for refining this model was the lack of experimental information for cellular composition, growth capabilities, and metabolite production under different media for validation. Most experimental data available for B. infantis are not readily applicable for model validation. GSMMs can simulate a phenotype in a specific environment. For a complex medium, approximations are employed, and care must be taken when interpreting simulation results. This adds a layer of uncertainty as the simulated production cannot be directly compared with experimental data if the simulation is deprived of some essential compound (83). Improvements in model simulations can be attained by adjusting the biomass reaction stoichiometry to experimental data such that growth and production/consumption capabilities match observations. In the case of this study, the best-performing biomass reaction was the AGORA v1.03 reaction (38), albeit the available data for testing was very limited (see Results). Condition-specific experimental data could help improve the current model’s quality, highlighting gaps in our understanding of B. infantis metabolism.

All Bifidobacterium produce lactate and acetate as part of their bifid shunt, with varying ratios depending on the substrate (6). However, their production is not well captured by metabolic models and remains an issue to improve in GSMMs. Here, the expected ratio of acetate to lactate was fixed, a solution that forces the model to produce lactate. This issue has been addressed differently in GSMMs of lactic acid bacteria that do not accurately represent lactate production (7, 33).

Compared to other reconstructions of Bifidobacterium, Devika et al. (7) used the AGORA model for B. infantis and added reactions for sialic acid and N-acetylglucosamine utilization. El-Semman et al. (37) presented a reconstruction for Bifidobacterium adolescentis with 454 genes and 699 reactions. Recently, Schöpping et al. (12) presented specific biomass stoichiometric equations for Bifidobacterium animalis and B. longum. The latter unfortunately did not produce satisfactory results for predicting biomass growth and yields in this study. Importantly, iLR578 stands as the most comprehensive genome-scale metabolic reconstruction of B. infantis reported to date, encompassing an increased number of genes, GPRs relations, and most importantly, metabolic capabilities.

Metabolites produced by Bifidobacterium are in the front line of the protective effect for the host attributed to this genus. Modifying their production might result in increased health benefits. Fucose and FL metabolism resulted in the most divergent metabolic profiles across three HMOs, strongly coupled to 1,2-PD production. The models resulting from this work predict formate being produced across all four substrates. However, experimental data suggest that formate in the infant gut derives mainly from FL and fucose metabolism (2). Finally, molecules produced at low quantities are complex to model, but it is well known that some might have a powerful effect on the host (84).

Lactate, acetate, formate, and ethanol production in B. infantis appeared interconnected, strongly coupling to adenine metabolism (Fig. 6). Adenine is a building block in riboflavin biosynthesis—an essential vitamin produced by B. infantis—suggesting HMO metabolism results in the constitutive production of riboflavin. Adenine is also related to purine metabolism, specifically DNA/RNA synthesis, which may also suggest a more direct and intuitive link to biomass biosynthesis and cellular growth. A coupling of succinate production in B. infantis to arginine biosynthesis was expected (6), but a connection between succinate and sulfate/sulfite metabolism deserves further investigation.

Conclusions

Bifidobacterium species are essential members of the gut microbiome. Their saccharolytic lifestyle enables them to thrive on different carbon sources. Bifidobacterium infantis is one of the most studied microorganisms for its ability to utilize different HMOs because of their genomic and functional adaptations, including ABC transporters and saccharolytic enzymes. Modeling these adaptations using GSMMs provides an opportunity for a better understanding of the physiological features of B. infantis upon utilization of different HMOs, ultimately supporting the design of probiotics. In this study, we built more comprehensive and refined GSMMs of B. infantis metabolism, integrating context-specific transcriptomic data under three different HMOs and lactose. This reconstruction (iLR578) recapitulated several differences in HMOs metabolism depending on the functional characteristics of the molecules. The production of major metabolites like acetate and lactate was common to all substrates, with a small production of succinate, formate, and ethanol. Differential production of compounds like 1,2-PD was observed in the fucosylated substrate. Finally, coupled reaction networks underpinning short-chain fatty acids production were identified under each condition, providing insights into their robustness and possible regulation. Overall, iLR578 constitutes a valuable platform for the scientific community to simulate B. infantis metabolism on different HMOs, which can be further expanded and improved as more experimental data become available.

ACKNOWLEDGMENTS

This work was funded in part by Agencia Nacional de Investigacion y Desarrollo Fondecyt Regular 1230764 and Fondequip EQM190070 (D.G.), ANID doctoral scholarship 21201171 (F.M.-A.), and the National Center for Artificial Intelligence CENIA FB210017 Basal ANID (P.A.S.).

Contributor Information

Daniel Garrido, Email: dgarridoc@ing.puc.cl.

Jack A. Gilbert, University of California San Diego, La Jolla, California, USA

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/msystems.00715-23.

Supplemental Information. msystems.00715-23-s0001.docx.

Tables S1 to S13 and Fig. S1 and S2.

DOI: 10.1128/msystems.00715-23.SuF1
Supplemental Data. msystems.00715-23-s0002.xlsx.

Additional data.

DOI: 10.1128/msystems.00715-23.SuF2
Legend. msystems.00715-23-s0003.docx.

Legend for Supplemental Data.

DOI: 10.1128/msystems.00715-23.SuF3

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Scholtens P, Oozeer R, Martin R, Amor KB, Knol J. 2012. The early settlers: intestinal microbiology in early life. Annu Rev Food Sci Technol 3:425–447. doi: 10.1146/annurev-food-022811-101120 [DOI] [PubMed] [Google Scholar]
  • 2. Tsukuda N, Yahagi K, Hara T, Watanabe Y, Matsumoto H, Mori H, Higashi K, Tsuji H, Matsumoto S, Kurokawa K, Matsuki T. 2021. Key bacterial taxa and metabolic pathways affecting gut short-chain fatty acid profiles in early life. ISME J 15:2574–2590. doi: 10.1038/s41396-021-00937-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Laursen MF, Sakanaka M, von Burg N, Mörbe U, Andersen D, Moll JM, Pekmez CT, Rivollier A, Michaelsen KF, Mølgaard C, Lind MV, Dragsted LO, Katayama T, Frandsen HL, Vinggaard AM, Bahl MI, Brix S, Agace W, Licht TR, Roager HM. 2021. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol 6:1367–1382. doi: 10.1038/s41564-021-00970-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Turroni F, Milani C, Ventura M, van Sinderen D. 2022. The human gut microbiota during the initial stages of life: insights from bifidobacteria. Curr Opin Biotechnol 73:81–87. doi: 10.1016/j.copbio.2021.07.012 [DOI] [PubMed] [Google Scholar]
  • 5. Fenster K, Freeburg B, Hollard C, Wong C, Rønhave Laursen R, Ouwehand AC. 2019. The production and delivery of probiotics: a review of a practical approach. Microorganisms 7:83. doi: 10.3390/microorganisms7030083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Pokusaeva K, Fitzgerald GF, van Sinderen D. 2011. Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6:285–306. doi: 10.1007/s12263-010-0206-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Devika NT, Raman K. 2019. Deciphering the metabolic capabilities of Bifidobacteria using genome-scale metabolic models. Sci Rep 9:18222. doi: 10.1038/s41598-019-54696-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. de Vos WM, Vaughan EE. 1994. Genetics of lactose utilization in lactic acid bacteria. FEMS Microbiol Rev 15:217–237. doi: 10.1111/j.1574-6976.1994.tb00136.x [DOI] [PubMed] [Google Scholar]
  • 9. Walsh C, Lane JA, van Sinderen D, Hickey RM. 2022. Human milk oligosaccharide-sharing by a consortium of infant derived Bifidobacterium species. Sci Rep 12:4143. doi: 10.1038/s41598-022-07904-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom H-J, Block DE, Mills DA. 2013. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol 33:262–270. doi: 10.1016/j.fm.2012.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Van der Meulen R, Adriany T, Verbrugghe K, De Vuyst L. 2006. Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production. Appl Environ Microbiol 72:5204–5210. doi: 10.1128/AEM.00146-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Schöpping M, Gaspar P, Neves AR, Franzén CJ, Zeidan AA. 2021. Identifying the essential nutritional requirements of the probiotic bacteria Bifidobacterium animalis and Bifidobacterium longum through genome-scale modeling. NPJ Syst Biol Appl 7:47. doi: 10.1038/s41540-021-00207-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Díaz R, Torres-Miranda A, Orellana G, Garrido D. 2021. Comparative genomic analysis of novel Bifidobacterium longum subsp. longum strains reveals functional divergence in the human gut microbiota. Microorganisms 9:1906. doi: 10.3390/microorganisms9091906 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Milani C, Turroni F, Duranti S, Lugli GA, Mancabelli L, Ferrario C, van Sinderen D, Ventura M. 2016. Genomics of the genus Bifidobacterium reveals species-specific adaptation to the glycan-rich gut environment. Appl Environ Microbiol 82:980–991. doi: 10.1128/AEM.03500-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DA. 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 105:18964–18969. doi: 10.1073/pnas.0809584105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Garrido D, Kim JH, German JB, Raybould HE, Mills DA. 2011. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS One 6:e17315. doi: 10.1371/journal.pone.0017315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom H-J, Joachimiak A, Lebrilla CB, Mills DA. 2012. Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Appl Environ Microbiol 78:795–803. doi: 10.1128/AEM.06762-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Thomson P, Medina DA, Garrido D. 2018. Human milk oligosaccharides and infant gut bifidobacteria: molecular strategies for their utilization. Food Microbiol 75:37–46. doi: 10.1016/j.fm.2017.09.001 [DOI] [PubMed] [Google Scholar]
  • 19. Duranti S, Lugli GA, Milani C, James K, Mancabelli L, Turroni F, Alessandri G, Mangifesta M, Mancino W, Ossiprandi MC, Iori A, Rota C, Gargano G, Bernasconi S, Di Pierro F, van Sinderen D, Ventura M. 2019. Bifidobacterium bifidum and the infant gut microbiota: an intriguing case of microbe-host co-evolution. Environ Microbiol 21:3683–3695. doi: 10.1111/1462-2920.14705 [DOI] [PubMed] [Google Scholar]
  • 20. Rodriguez CI, Martiny JBH. 2020. Evolutionary relationships among bifidobacteria and their hosts and environments. BMC Genomics 21:26. doi: 10.1186/s12864-019-6435-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Soyyılmaz B, Mikš MH, Röhrig CH, Matwiejuk M, Meszaros-Matwiejuk A, Vigsnæs LK. 2021. The mean of milk: a review of human milk oligosaccharide concentrations throughout lactation. Nutrients 13:2737. doi: 10.3390/nu13082737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, Ruhaak LR, Darboe MK, German JB, Prentice AM, Lebrilla CB. 2012. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res 11:6124–6133. doi: 10.1021/pr300769g [DOI] [PubMed] [Google Scholar]
  • 23. German JB, Lebrilla C, Mills DA. 2022. Milk: a scientific model for diet and health research in the 21st century. Front Nutr 9:922907. doi: 10.3389/fnut.2022.922907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Garrido D, Ruiz-Moyano S, Kirmiz N, Davis JC, Totten SM, Lemay DG, Ugalde JA, German JB, Lebrilla CB, Mills DA. 2016. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596. Sci Rep 6:35045. doi: 10.1038/srep35045 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Turroni F, Bottacini F, Foroni E, Mulder I, Kim J-H, Zomer A, Sánchez B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly D, van Sinderen D, Ventura M. 2010. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 107:19514–19519. doi: 10.1073/pnas.1011100107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Martin AJM, Serebrinsky-Duek K, Riquelme E, Saa PA, Garrido D. 2023. Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium. Microbiome Res Rep 2:17. doi: 10.20517/mrr.2023.10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Masi AC, Stewart CJ. 2022. Untangling human milk oligosaccharides and infant gut microbiome. iScience 25:103542. doi: 10.1016/j.isci.2021.103542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Garrido D, Ruiz-Moyano S, Lemay DG, Sela DA, German JB, Mills DA. 2015. Comparative transcriptomics reveals key differences in the response to milk oligosaccharides of infant gut-associated bifidobacteria. Sci Rep 5:13517. doi: 10.1038/srep13517 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ruiz-Moyano S, Totten SM, Garrido DA, Smilowitz JT, German JB, Lebrilla CB, Mills DA. 2013. Variation in consumption of human milk oligosaccharides by infant gut-associated strains of bifidobacterium breve. Appl Environ Microbiol 79:6040–6049. doi: 10.1128/AEM.01843-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Duar RM, Casaburi G, Mitchell RD, Scofield LNC, Ortega Ramirez CA, Barile D, Henrick BM, Frese SA. 2020. Comparative genome analysis of Bifidobacterium longum subsp. infantis strains reveals variation in human milk oligosaccharide utilization genes among commercial probiotics. Nutrients 12:3247. doi: 10.3390/nu12113247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Li M, Zhou X, Stanton C, Ross RP, Zhao J, Zhang H, Yang B, Chen W. 2021. Comparative genomics analyses reveal the differences between B. longum subsp. infantis and B. longum subsp. longum in carbohydrate utilisation, CRISPR-Cas systems and bacteriocin operons. Microorganisms 9:1713. doi: 10.3390/microorganisms9081713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Sakanaka M, Hansen ME, Gotoh A, Katoh T, Yoshida K, Odamaki T, Yachi H, Sugiyama Y, Kurihara S, Hirose J, Urashima T, Xiao J-Z, Kitaoka M, Fukiya S, Yokota A, Lo Leggio L, Abou Hachem M, Katayama T. 2019. Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis. Sci Adv 5:eaaw7696. doi: 10.1126/sciadv.aaw7696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Sen P, Orešič M. 2019. Metabolic modeling of human gut microbiota on a genome scale: an overview. Metabolites 9:22. doi: 10.3390/metabo9020022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Altamirano Á, Saa PA, Garrido D. 2020. Inferring composition and function of the human gut microbiome in time and space: a review of genome-scale metabolic modelling tools. Comput Struct Biotechnol J 18:3897–3904. doi: 10.1016/j.csbj.2020.11.035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Becker SA, Palsson BO. 2008. Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol 4:e1000082. doi: 10.1371/journal.pcbi.1000082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Machado D, Herrgård M. 2014. Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolism. PLOS Comput Biol 10:e1003580. doi: 10.1371/journal.pcbi.1003580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. El-Semman IE, Karlsson FH, Shoaie S, Nookaew I, Soliman TH, Nielsen J. 2014. Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction. BMC Syst Biol 8:41. doi: 10.1186/1752-0509-8-41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Magnúsdóttir S, Heinken A, Kutt L, Ravcheev DA, Bauer E, Noronha A, Greenhalgh K, Jäger C, Baginska J, Wilmes P, Fleming RMT, Thiele I. 2017. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat Biotechnol 35:81–89. doi: 10.1038/nbt.3703 [DOI] [PubMed] [Google Scholar]
  • 39. Chen I-M, Chu K, Palaniappan K, Ratner A, Huang J, Huntemann M, Hajek P, Ritter S, Varghese N, Seshadri R, Roux S, Woyke T, Eloe-Fadrosh EA, Ivanova NN, Kyrpides NC. 2021. The IMG/M data management and analysis system v.6.0: new tools and advanced capabilities. Nucleic Acids Res 49:D751–D763. doi: 10.1093/nar/gkaa939 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Disz T, Akhter S, Cuevas D, Olson R, Overbeek R, Vonstein V, Stevens R, Edwards RA. 2010. Accessing the SEED genome databases via web services API: tools for programmers. BMC Bioinformatics 11:319. doi: 10.1186/1471-2105-11-319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Heirendt L, Arreckx S, Pfau T, Mendoza SN, Richelle A, Heinken A, Haraldsdóttir HS, Wachowiak J, Keating SM, Vlasov V, et al. 2019. Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0. Nat Protoc 14:639–702. doi: 10.1038/s41596-018-0098-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Orth JD, Thiele I, Palsson BØ. 2010. What is flux balance analysis Nat Biotechnol 28:245–248. doi: 10.1038/nbt.1614 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. 2016. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44:D457–D462. doi: 10.1093/nar/gkv1070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. King ZA, Lu J, Dräger A, Miller P, Federowicz S, Lerman JA, Ebrahim A, Palsson BO, Lewis NE. 2016. BiGG Models: a platform for integrating, standardizing and sharing genome-scale models. Nucleic Acids Res 44:D515–D522. doi: 10.1093/nar/gkv1049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Lieven C, Beber ME, Olivier BG, Bergmann FT, Ataman M, Babaei P, Bartell JA, Blank LM, Chauhan S, Correia K, et al. 2020. MEMOTE for standardized genome-scale metabolic model testing. Nat Biotechnol 38:272–276. doi: 10.1038/s41587-020-0446-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data
  • 47. Ewels P, Magnusson M, Lundin S, Käller M. 2016. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32:3047–3048. doi: 10.1093/bioinformatics/btw354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi: 10.1038/nmeth.1923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Bushnell B. 2014. BBMap: a fast, accurate, splice-aware aligner (No. LBNL-7065E). Berkeley, CA (United States) Lawrence Berkeley National Lab.(LBNL) [Google Scholar]
  • 51. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. 2019. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37:907–915. doi: 10.1038/s41587-019-0201-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. doi: 10.1186/s13059-014-0550-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Lewis NE, Hixson KK, Conrad TM, Lerman JA, Charusanti P, Polpitiya AD, Adkins JN, Schramm G, Purvine SO, Lopez-Ferrer D, Weitz KK, Eils R, König R, Smith RD, Palsson BØ. 2010. Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol Syst Biol 6:390. doi: 10.1038/msb.2010.47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. De Martino D, Capuani F, Mori M, De Martino A, Marinari E. 2013. Counting and correcting thermodynamically infeasible flux cycles in genome-scale metabolic networks. Metabolites 3:946–966. doi: 10.3390/metabo3040946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Saa PA, Nielsen LK. 2016. Fast-SNP: a fast matrix pre-processing algorithm for efficient loopless flux optimization of metabolic models. Bioinformatics 32:3807–3814. doi: 10.1093/bioinformatics/btw555 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Saa PA, Nielsen LK. 2016. ll-ACHRB: a scalable algorithm for sampling the feasible solution space of metabolic networks. Bioinformatics 32:2330–2337. doi: 10.1093/bioinformatics/btw132 [DOI] [PubMed] [Google Scholar]
  • 57. Mahadevan R, Schilling CH. 2003. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 5:264–276. doi: 10.1016/j.ymben.2003.09.002 [DOI] [PubMed] [Google Scholar]
  • 58. Bunesova V, Lacroix C, Schwab C. 2016. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense. BMC Microbiol 16:248. doi: 10.1186/s12866-016-0867-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Corona L, Lussu A, Bosco A, Pintus R, Cesare Marincola F, Fanos V, Dessì A. 2021. Human milk oligosaccharides: a comprehensive review towards metabolomics. Children (Basel) 8:804. doi: 10.3390/children8090804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Dedon LR, Özcan E, Rani A, Sela DA. 2020. Bifidobacterium infantis metabolizes 2′fucosyllactose-derived and free fucose through a common catabolic pathway resulting in 1,2-propanediol secretion. Front Nutr 7:583397. doi: 10.3389/fnut.2020.583397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Garrido D, Ruiz-Moyano S, Mills DA. 2012. Release and utilization of N-acetyl-d-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe 18:430–435. doi: 10.1016/j.anaerobe.2012.04.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Kim J-H, An HJ, Garrido D, German JB, Lebrilla CB, Mills DA, de Crécy-Lagard V. 2013. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLoS ONE 8:e57535. doi: 10.1371/journal.pone.0057535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Lugli GA, Mancino W, Milani C, Duranti S, Turroni F, van Sinderen D, Ventura M, McBain AJ. 2018. Reconstruction of the bifidobacterial pan-secretome reveals the network of extracellular interactions between bifidobacteria and the infant gut. Appl Environ Microbiol 84:1–12. doi: 10.1128/AEM.00796-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Ojima MN, Asao Y, Nakajima A, Katoh T, Kitaoka M, Gotoh A, Hirose J, Urashima T, Fukiya S, Yokota A, Abou Hachem M, Sakanaka M, Katayama T. 2022. Diversification of a fucosyllactose transporter within the genus Bifidobacterium. Appl Environ Microbiol 88:e0143721. doi: 10.1128/AEM.01437-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Özcan E, Sela DA. 2018. Inefficient metabolism of the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose shifts Bifidobacterium longum subsp. infantis physiology. Front. Nutr 5:46. doi: 10.3389/fnut.2018.00046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Zabel BE, Gerdes S, Evans KC, Nedveck D, Singles SK, Volk B, Budinoff C. 2020. Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697. Sci Rep 10:15919. doi: 10.1038/s41598-020-72792-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Zabel B, Yde CC, Roos P, Marcussen J, Jensen HM, Salli K, Hirvonen J, Ouwehand AC, Morovic W. 2019. Novel genes and metabolite trends in Bifidobacterium longum subsp. infantis Bi-26 metabolism of human milk oligosaccharide 2′-fucosyllactose. Sci Rep 9:7983. doi: 10.1038/s41598-019-43780-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Mendoza SN, Olivier BG, Molenaar D, Teusink B. 2019. A systematic assessment of current genome-scale metabolic reconstruction tools. Genome Biol 20:158. doi: 10.1186/s13059-019-1769-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Chicco D, Tötsch N, Jurman G. 2021. The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation. BioData Min 14:13. doi: 10.1186/s13040-021-00244-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. King ZA, Dräger A, Ebrahim A, Sonnenschein N, Lewis NE, Palsson BO. 2015. Escher: a web application for building, sharing, and embedding data-rich visualizations of biological pathways. PLoS Comput Biol 11:e1004321. doi: 10.1371/journal.pcbi.1004321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Larhlimi A, David L, Selbig J, Bockmayr A. 2012. F2C2: a fast tool for the computation of flux coupling in genome-scale metabolic networks. BMC Bioinformatics 13:57. doi: 10.1186/1471-2105-13-57 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape:a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. doi: 10.1101/gr.1239303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Gomes de Oliveira Dal’Molin C, Quek L-E, Saa PA, Nielsen LK. 2015. A multi-tissue genome-scale metabolic modeling framework for the analysis of whole plant systems. Front Plant Sci 6:4. doi: 10.3389/fpls.2015.00004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Goenawan IH, Bryan K, Lynn DJ. 2016. DyNet: visualization and analysis of dynamic molecular interaction networks. Bioinformatics 32:2713–2715. doi: 10.1093/bioinformatics/btw187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards RA, Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F, Stevens R. 2014. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res 42:D206–14. doi: 10.1093/nar/gkt1226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Saa P, Urrutia A, Silva-Andrade C, Martín AJ, Garrido D. 2022. Modeling approaches for probing cross-feeding interactions in the human gut microbiome. Comput Struct Biotechnol J 20:79–89. doi: 10.1016/j.csbj.2021.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Garrido D, Dallas DC, Mills DA. 2013. Consumption of human milk glycoconjugates by infant-associated bifidobacteria: mechanisms and implications. Microbiology (Reading) 159:649–664. doi: 10.1099/mic.0.064113-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Cheng L, Kiewiet MBG, Logtenberg MJ, Groeneveld A, Nauta A, Schols HA, Walvoort MTC, Harmsen HJM, de Vos P. 2020. Effects of different human milk oligosaccharides on growth of Bifidobacteria in monoculture and co-culture with Faecalibacterium prausnitzii. Front Microbiol 11:569700. doi: 10.3389/fmicb.2020.569700 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. You X, Lyu Y, Sela DA. 2016. The participation of an infant harbored bacterial commensal in urea nitrogen salvaging. The FASEB Journal 30:673. doi: 10.1096/fasebj.30.1_supplement.673.3 [DOI] [Google Scholar]
  • 80. Metris A, Reuter M, Gaskin DJH, Baranyi J, van Vliet AHM. 2011. In vivo and in silico determination of essential genes of Campylobacter jejuni. BMC Genomics 12:535. doi: 10.1186/1471-2164-12-535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Burgard AP, Nikolaev EV, Schilling CH, Maranas CD. 2004. Flux coupling analysis of genome-scale metabolic network reconstructions. Genome Res 14:301–312. doi: 10.1101/gr.1926504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Wu J, Tan S-Y, Liu Z, Tan Y-J, Lu X. 2017. Enhancing structural robustness of scale-free networks by information disturbance. Sci Rep 7:7559. doi: 10.1038/s41598-017-07878-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Bernstein DB, Sulheim S, Almaas E, Segrè D. 2021. Addressing uncertainty in genome-scale metabolic model reconstruction and analysis. Genome Biol 22:64. doi: 10.1186/s13059-021-02289-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Henrick BM, Rodriguez L, Lakshmikanth T, Pou C, Henckel E, Arzoomand A, Olin A, Wang J, Mikes J, Tan Z, et al. 2021. Bifidobacteria-mediated immune system imprinting early in life. Cell 184:3884–3898. doi: 10.1016/j.cell.2021.05.030 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Information. msystems.00715-23-s0001.docx.

Tables S1 to S13 and Fig. S1 and S2.

DOI: 10.1128/msystems.00715-23.SuF1
Supplemental Data. msystems.00715-23-s0002.xlsx.

Additional data.

DOI: 10.1128/msystems.00715-23.SuF2
Legend. msystems.00715-23-s0003.docx.

Legend for Supplemental Data.

DOI: 10.1128/msystems.00715-23.SuF3

Articles from mSystems are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES